Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Jichun Yang
Shuqing Yu
Zhirong Yang
Yusong Yan
Yao Chen
Hongmei Zeng
Fei Ma
Yanxia Shi
Yehui Shi
Zilu Zhang
Feng Sun
机构：
[1] Peking University,Department of Epidemiology and Biostatistics, School of Public Health
[2] University of Cambridge,Primary Care Unit, School of Clinical Medicine
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[4] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[5] Sun Yat-Sen University Cancer Center/State Key Laboratory of Oncology in South China/Collaborative Innovation Center for Cancer Medicine,Department of Medical Oncology
[6] Phase I Clinical Trial Department of Tianjin Medical University Cancer Institute and Hospital,undefined
[7] Harvard Medical School and Harvard Pilgrim Health Care Institute,undefined
来源：
BioDrugs | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：357 / 371
页数：14
相关论文
共 50 条
  • [1] Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yang, Jichun
    Yu, Shuqing
    Yang, Zhirong
    Yan, Yusong
    Chen, Yao
    Zeng, Hongmei
    Ma, Fei
    Shi, Yanxia
    Shi, Yehui
    Zhang, Zilu
    Sun, Feng
    [J]. BIODRUGS, 2019, 33 (04) : 357 - 371
  • [2] Safety and efficacy of anti-cancer biosimilars compared to their reference biologics: Systematic review with meta-analysis
    Song, Nina K.
    Musa, Hala
    Soriano, Michael
    Ong, Jennifer
    Hawkins, Bryson
    Batger, Mellissa
    Ramzan, Iqbal
    Hibbs, David E.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 166 - 167
  • [3] Comparative efficacy and safety of trastuzumab biosimilars to the reference drug: a systematic review and meta-analysis of randomized clinical trials
    Cargnin, Sarah
    Shin, Jae Il
    Genazzani, Armando A.
    Nottegar, Alessia
    Terrazzino, Salvatore
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (05) : 577 - 588
  • [4] Comparative efficacy and safety of trastuzumab biosimilars to the reference drug: a systematic review and meta-analysis of randomized clinical trials
    Sarah Cargnin
    Jae Il Shin
    Armando A. Genazzani
    Alessia Nottegar
    Salvatore Terrazzino
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 86 : 577 - 588
  • [5] Safety of acupuncture in oncology: A systematic review and meta-analysis of randomized controlled trials
    Hoxtermann, Melanie D.
    Haller, Heidemarie
    Aboudamaah, Shaimaa
    Bachemir, Armin
    Dobos, Gustav
    Cramer, Holger
    Voiss, Petra
    [J]. CANCER, 2022, 128 (11) : 2159 - 2173
  • [6] Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis
    Herndon, Thomas M.
    Ausin, Cristina
    Brahme, Nina N.
    Schrieber, Sarah J.
    Luo, Michelle
    Andrada, Frances C.
    Kim, Carol
    Sun, Wanjie
    Zhou, Lingjie
    Grosser, Stella
    Yim, Sarah
    Ricci, M. Stacey
    [J]. PLOS ONE, 2023, 18 (10):
  • [7] Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ye, Ziqi
    Yang, Wenchao
    Xuan, Bixia
    Li, Xiaofang
    He, Jiana
    Si, Haiyan
    Ma, Wenhua
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Safety and efficacy of perampanel in epilepsy: A systematic review and meta-analysis of randomized controlled trials
    Lavu, Alekhya
    Aboulatta, Laila Nabil Mahmoud Helmy
    Abou-Setta, Ahamed M.
    Aloud, Basma
    Askin, Nicole
    Rabbani, Rasheda
    Shouman, Walid
    Zarychanski, Ryan
    Eltonsy, Sherif
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 329 - 330
  • [9] Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
    Guedeney, Paul
    Giustino, Gennaro
    Sorrentino, Sabato
    Claessen, Bimmer E.
    Camaj, Anton
    Kalkman, Deborah N.
    Vogel, Birgit
    Sartori, Samantha
    De Rosa, Salvatore
    Baber, Usman
    Indolfi, Ciro
    Montalescot, Gilles
    Dangas, George D.
    Rosenson, Robert S.
    Pocock, Stuart J.
    Mehran, Roxana
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (07) : E17 - E25
  • [10] Efficacy and safety of lorcaserin in obesity: a systematic review and meta-analysis of randomized controlled trials
    Singh, Awadhesh Kumar
    Singh, Ritu
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 183 - 190
12345